Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes
Authors
Keywords
-
Journal
Redox Biology
Volume 66, Issue -, Pages 102849
Publisher
Elsevier BV
Online
2023-08-14
DOI
10.1016/j.redox.2023.102849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP‑1 receptor agonist protects palmitate-induced insulin resistance in skeletal muscle cells by up-regulating sestrin2 to promote autophagy
- (2023) Xue Tian et al. Scientific Reports
- Roux-en-Y Gastric Bypass Modulates AMPK, Autophagy and Inflammatory Response in Leukocytes of Obese Patients
- (2022) Zaida Abad-Jiménez et al. Biomedicines
- Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1/Parkin-dependent mitophagy
- (2022) Yikai Zhang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart Failure
- (2022) Persio David Lopez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients
- (2022) Aranzazu M. de Marañón et al. Redox Biology
- GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
- (2022) Nikolaus Marx et al. CIRCULATION
- The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study
- (2021) Juraj Koska et al. DIABETES CARE
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Relationship between PMN-endothelium interactions, ROS production and Beclin-1 in type 2 diabetes
- (2020) Aranzazu M. De Marañon et al. Redox Biology
- Association between Proinflammatory Markers, Leukocyte–Endothelium Interactions, and Carotid Intima–Media Thickness in Type 2 Diabetes: Role of Glycemic Control
- (2020) Aranzazu Martinez de Marañón et al. Journal of Clinical Medicine
- Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy
- (2020) Rong-Hua Zheng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
- (2020) Brent A McLean et al. ENDOCRINE REVIEWS
- Liraglutide prevents β-cells apoptosis via inactivation of NOX2 and its related signaling pathway
- (2019) Min Ding et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Epidemiology of Diabetes Mellitus and Cardiovascular Disease
- (2019) Diana Glovaci et al. Current Cardiology Reports
- Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult
- (2019) Mohammad Sarif Mohiuddin et al. Journal of Diabetes Research
- Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease
- (2019) Celestino Sardu et al. Journal of Diabetes Research
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art
- (2019) Speranza Rubattu et al. Oxidative Medicine and Cellular Longevity
- The Vasculature in Prediabetes
- (2018) David H. Wasserman et al. CIRCULATION RESEARCH
- Reactive Oxygen Species in Metabolic and Inflammatory Signaling
- (2018) Steven J. Forrester et al. CIRCULATION RESEARCH
- Clinical impact of oral antidiabetic medications in heart failure patients
- (2018) Alberto Palazzuoli et al. HEART FAILURE REVIEWS
- The Role of Leukocytes in Diabetic Cardiomyopathy
- (2018) Anamika Bajpai et al. Frontiers in Physiology
- Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
- (2017) Giovanna Muscogiuri et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Carotid Intima-Media Thickness for Atherosclerosis
- (2016) Tomohisa Nezu et al. Journal of Atherosclerosis and Thrombosis
- Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
- (2016) John J. Lepore et al. JACC-Heart Failure
- Disruption of Renal Tubular Mitochondrial Quality Control by Myo-Inositol Oxygenase in Diabetic Kidney Disease
- (2014) M. Zhan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of Interleukin-6 With the Progression of Carotid Atherosclerosis
- (2014) Shuhei Okazaki et al. STROKE
- Human Leukocyte/Endothelial Cell Interactions and Mitochondrial Dysfunction in Type 2 Diabetic Patients and Their Association With Silent Myocardial Ischemia
- (2013) A. Hernandez-Mijares et al. DIABETES CARE
- Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
- (2013) Andrew E. Hogan et al. DIABETOLOGIA
- ROS production in phagocytes: why, when, and where?
- (2013) Sophie Dupré-Crochet et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes
- (2012) Kui-Kai Lau et al. Cardiovascular Diabetology
- Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study
- (2012) Bo Zhao et al. Cardiovascular Diabetology
- Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
- (2012) Aaron S Kelly et al. Cardiovascular Diabetology
- Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients
- (2011) Antonio Hernandez-Mijares et al. FREE RADICAL BIOLOGY AND MEDICINE
- Induction of Oxidative Stress and Human Leukocyte/Endothelial Cell Interactions in Polycystic Ovary Syndrome Patients with Insulin Resistance
- (2011) Victor M. Victor et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Increased Recruitment but Impaired Function of Leukocytes during Inflammation in Mouse Models of Type 1 and Type 2 Diabetes
- (2011) Ulrika Sofia Pettersson et al. PLoS One
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
- (2009) M. H. Noyan-Ashraf et al. DIABETES
- The Pathologic Continuum of Diabetic Vascular Disease
- (2009) Gabriela Orasanu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search